The European Medicines Agency (EMA) has completed a review of the obesity medicine sibutramine (Reductil) on the basis of new safety information from a large clinical trial, the Sibutramine Cardiovascular OUTcomes (SCOUT) study. The review has found that the cardiovascular risks of sibutramine outweigh its benefits. The EMA’s Committee for Medicinal Products for Human Use (CHMP) has recommended suspension of the marketing authorisation for this medicine across the European Union.
Further information is available on the EMA website.
Pharmacists are now unable to dispense Reductil and Doctors are also unable to write prescriptions for the obesity medication.
If you are looking for some help with losing some weight after the New Year Xenical is still the best option as Xenical is a lipase inhibitor and does not enter the patient's blood stream, but works in the digestive system in the small intestine as a fat absorber. It blocks out a third of the fat in food eaten in a patient's diet, leading to steady weight loss. Buy Xenical online at www.medical-specialists.co.uk
This comment has been removed by the author.
ReplyDeleteFor a modest additional loss of 5-6 lbs. a year not sure Xenical's digestive issues (flatulence, anal leakage) are worth it. Sounds like the same symptoms caused by Wow chips.
ReplyDelete